Question 1

What is Sresan Pharmaceuticals?

Accepted Answer

Sresan Pharmaceuticals is a Entity.

Question 2

How often does Sresan Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 4 news events drawn from 32 articles.

Question 3

When was Sresan Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Oct 05, 2025.

Question 4

When was Sresan Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Jun 16, 2026.

Question 5

What is Sresan Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: -100 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Sresan Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 4 events.

Question 7

What is the most recent event involving Sresan Pharmaceuticals?

Accepted Answer

Toxic Coldrif Syrup Kills Children (Oct 05, 2025, 7 articles).

Question 8

How did the "Toxic Coldrif Syrup Kills Children" event impact Sresan Pharmaceuticals?

Accepted Answer

Sresan Pharmaceuticals, the manufacturer of Coldrif syrup cough syrup, is facing an FIR and investigation after its product was found to contain lethal levels of diethylene glycol, causing numerous child deaths. The company's products have been banned.

Question 9

How did the "India Coldrif Cough Syrup Ban" event impact Sresan Pharmaceuticals?

Accepted Answer

Sresan Pharmaceuticals manufactured the contaminated Coldrif cough syrup, leading to multiple child deaths, criminal charges, and recommendations for license cancellation.

Question 10

How did the "Sresan Pharmaceutical Shut Down Over Toxic Syrup" event impact Sresan Pharmaceuticals?

Accepted Answer

Sresan Pharmaceuticals's manufacturing license was revoked and the company was shut down due to producing adulterated cough syrup, leading to multiple child deaths. Its owner was arrested, and its premises were raided by the India — Enforcement Directorate.

Question 11

How did the "ED Attaches Sresan Pharma Owner Assets" event impact Sresan Pharmaceuticals?

Accepted Answer

Sresan Pharmaceuticals is accused of using industry-grade raw materials instead of pharma-grade materials to produce the cough syrup Coldrif, which led to the death of 22 children in India — Madhya Pradesh. The company's manufacturing unit was ordered to be closed.

Question 12

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.